Treatment of shingles patients with a new method

Investigation of the treatment effect of Koiran Amin antiviral syrup and Sadra Nora anti-herpes alium ointment in patients with shingles

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200504047295N2

Enrollment

Registered

2025-12-29

Start date

2026-02-20

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster. Zoster [herpes zoster]

Interventions

Intervention 1: Intervention group: first group of patients will receive co-iran Amin syrup orally for two weeks along with topical Alium Sadra Noor ointment. Intervention 2: Control group: The second

Eligibility

Sex/Gender

All

Age

25 Years to No maximum

Inclusion criteria

Inclusion criteria: patients must be digsoned by shingles . All patients should have clinical symptoms of shingles such as body pain and skin rashes.

Exclusion criteria

Exclusion criteria: Individuals who exhibit specific allergic reactions to shallomin syrup. Pregnant women (based on WHO protocol)

Design outcomes

Primary

Measure	Time frame
Number of people with shingles. Timepoint: 14 days. Method of measurement: Comparison of the speed and process of improvement in clinical symptoms between the two groups receiving Co-Iran Amin syrup and Sadra Noor Allium ointment with the group receiving topical and oral acyclovir.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansour Amin

Ahvaz University of Medical Sciences

mnsamin@yahoo.com+98 61 3311 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026